MESA, AZ / ACCESS Newswire / September 16, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that it has ...

BALDWIN COUNTY, Ala. (WKRG) — What if doctors could build a vaccine to fight your specific cancer? That’s the idea behind a ...

A personalized mRNA vaccine paired with Keytruda may help keep skin cancer from returning after surgery, a large clinical trial suggests.

A history of keratinocyte carcinoma was associated with more than four times the odds of mucosal melanoma, study reports.

The symposium will take place on Saturday, Sept. 26, from 8 a.m. to 3 p.m., and will be held in person on Johns Hopkins East Baltimore campus. Registration required.

Pharmaceutical giants Moderna and Merck said that an experimental vaccine treatment has shown signs of preventing skin cancer from returning or spreading in a study of melanoma patients.

Cancers actively remodel their surrounding cells and tissues to create a microenvironment that favors their growth, survival, and spread.

Moderna Inc. (NASDAQ:MRNA) saw its share price more than double week-on-week to hit a new record high after reporting stellar results from the clinical trial of its melanoma therapy candidate in ...

Moderna and Merck announced study results that reflect a "landmark moment" in treatment for one of the deadliest forms of skin cancer.

Melanoma can spread to many tissues in your body including your brain. Treatment for melanoma that has spread to the brain usually focuses on prolonging life and reducing symptoms. Melanoma is the ...

Veterans with melanoma have a 47% higher risk for developing Parkinson’s disease compared with veterans without melanoma, ...

Melanocytic nevi, which are benign tumors of melanocytes, may have occasional cosmetic significance but, for the most part, they are important only in relation to melanoma. Nevi are the most important ...